Regulation of NFKBIZ gene promoter activity by STAT3, C/EBPβ, and STAT1
- 3 May 2022
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 613, 61-66
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (17K08263, 19H03364, 20K07010)
- Suhara Memorial Foundation
This publication has 37 references indexed in Scilit:
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- STAT1Mutations in Autosomal Dominant Chronic Mucocutaneous CandidiasisNew England Journal of Medicine, 2011
- Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisJournal of Experimental Medicine, 2011
- Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In VivoThe Journal of Immunology, 2011
- Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunityFrontiers in Bioscience-Landmark, 2011
- Roles of unphosphorylated STATs in signalingCell Research, 2008
- IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- IκB‐ζ: An Inducible Regulator of Nuclear Factor‐κB2006
- Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse modelNature Medicine, 2004
- Involvement of NF- B in TGF- -mediated suppression of IL-4 signalingBiochemical and Biophysical Research Communications, 2004